RxDoctor Payments Data

Charles Bailey, MD

Vascular Surgery · Tampa, FLNPI 1265619365

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $128,340 of the $162,321 with a category attached, or 79.1%. 17 manufacturers reported payments, led by Cook Incorporated at 42.4% of the total. Among vascular surgery clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$162,321in general payments, 2019–2025

Across 248 payments — averaging $654.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cook Incorporated$69K
  • Penumbra, Inc.$56K
  • Shockwave Medical, Inc$15K
  • Silk Road Medical, Inc.$13K
  • Cook Medical LLC$5K
  • Boston Scientific$3K
  • plus $3K from 11 others
$17,500in research payments, 2019–2025

Across 1 payment — averaging $17,500 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Penumbra, Inc.$18K

What the payments were for

  • Consulting fees$6,2004%
  • Speaking & faculty fees$128,34079%
  • Travel & lodging$13,2418%
  • Food & beverage$14,5409%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$162,321 in reported general payments places this provider in the 95th percentile of 385 vascular surgery providers in Florida.

See all vascular surgery providers in Florida

Medicare billing

Part B allowed, 2024
$154,688
Medicare patients
289
Services billed
694

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban18$18,596
ClopidogrelClopidogrel Bisulfate110$1,140
Cilostazol57$729

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →